Chinese Medicine for Chronic Obstructive Pulmonary Disease: A Pilot Study on Patient Preferences

References

• Rogliani P, Ora J, Puxeddu E, Matera MG, Cazzola M. Adherence to copd treatment: myth and reality. Respir Med. 2017;129:117–123. doi:10.1016/j.rmed.2017.06.007
   PubMed Web of Science ®Google Scholar
• Bender BG. Nonadherence in chronic obstructive pulmonary disease patients: what do we know and what should we do next? Curr Opin Pulm Med. 2014;20(2):132–137. doi:10.1097/MCP.0000000000000027
   PubMed Web of Science ®Google Scholar
• Haupt D, Krigsman K, Nilsson JL. Medication persistence among patients with asthma/copd drugs. Pharm World Sci. 2008;30(5):509–514. doi:10.1007/s11096-008-9197-4
   PubMed Web of Science ®Google Scholar
• Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for copd. Int J Chron Obstruct Pulmon Dis. 2008;3(3):371–384. doi:10.2147/COPD.S3036
   PubMedGoogle Scholar
• Bourbeau J, Bartlett SJ. Patient adherence in copd. Thorax. 2008;63(9):831–838. doi:10.1136/thx.2007.086041
   PubMed Web of Science ®Google Scholar
• George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with copd. Chest. 2005;128(5):3198–3204. doi:10.1378/chest.128.5.3198
   PubMed Web of Science ®Google Scholar
• Guyatt G, Rennie D, Meade MO, Deborah J. Cook. Users’guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 3rd ed. New York: McGraw Hill Education & The JAMA Network; 2015.
   Google Scholar
• Blinman P, King M, Norman R, Viney R, Stockler MR. Preferences for cancer treatments: an overview of methods and applications in oncology. Ann Oncol. 2012;23(5):1104–1110. doi:10.1093/annonc/mdr559
   PubMed Web of Science ®Google Scholar
• Kawata AK, Kleinman L, Harding G, Ramachandran S. Evaluation of patient preference and willingness to pay for attributes of maintenance medication for chronic obstructive pulmonary disease (copd). patient. 2014;7(4):413–426. doi:10.1007/s40271-014-0064-1
   PubMedGoogle Scholar
• Miravitlles M, Anzueto A, Legnani D, Forstmeier L, Fargel M. Patient’s perception of exacerbations of copd--the perceive study. Respir Med. 2007;101(3):453–460. doi:10.1016/j.rmed.2006.07.010
   PubMed Web of Science ®Google Scholar
• Utens CM, Goossens LM, van Schayck OC, et al. Patient preference and satisfaction in hospital-at-home and usual hospital care for copd exacerbations: results of a randomised controlled trial. Int J Nurs Stud. 2013;50(11):1537–1549. doi:10.1016/j.ijnurstu.2013.03.006
   PubMed Web of Science ®Google Scholar
• O’Hagan P, Dederichs J, Viswanad B, Gasser M, Walda S. Patient preference for a maintenance inhaler in chronic obstructive pulmonary disease: a comparison of breezhaler and respimat. J Thorac Dis. 2018;10(10):5727–5735. doi:10.21037/jtd.2018.09.126
   PubMed Web of Science ®Google Scholar
• Chouaid C, Germain N, De Pouvourville G, et al. Patient preference for chronic obstructive pulmonary disease (copd) treatment inhalers: a discrete choice experiment in france. Curr Med Res Opin. 2019;35(5):785–792. doi:10.1080/03007995.2019.1574507
   PubMed Web of Science ®Google Scholar
• Liu S, Shergis J, Chen X, et al. Chinese herbal medicine (weijing decoction) combined with pharmacotherapy for the treatment of acute exacerbations of chronic obstructive pulmonary disease. Evid Based Complement Alternat Med. 2014;2014:257012. doi:10.1155/2014/257012
   Web of Science ®Google Scholar
• Chen Y, Shergis JL, Wu L, et al. A systematic review and meta-analysis of the herbal formula Buzhong Yiqi Tang for stable chronic obstructive pulmonary disease. Complement Ther Med. 2016;29:94–108. doi:10.1016/j.ctim.2016.09.017
   PubMed Web of Science ®Google Scholar
• Chen X, May B, Di YM, et al. Oral Chinese herbal medicine combined with pharmacotherapy for stable COPD: a systematic review of effect on BODE index and six minute walk test. PLoS One. 2014;9(3):e91830. doi:10.1371/journal.pone.0091830
   Web of Science ®Google Scholar
• Coyle ME, Shergis JL, Huang ET, et al. Acupuncture therapies for chronic obstructive pulmonary disease: a systematic review of randomized, controlled trials. Altern Ther Health Med. 2014;20(6):10–23.
   PubMed Web of Science ®Google Scholar
• Guo C, Xiang G, Xie L, et al. Effects of Tai Chi training on the physical and mental health status in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Thorac Dis. 2020;12(3):504–521. doi:10.21037/jtd.2020.01.03
   PubMed Web of Science ®Google Scholar
• Ma J, Zheng J, Zhong N, et al. Effects of yupingfeng granules on acute exacerbations of copd: a randomized, placebo-controlled study. Int J Chron Obstruct Pulmon Dis. 2018;13:3107–3114. doi:10.2147/COPD.S170555
   PubMed Web of Science ®Google Scholar
• Shergis JL, Thien F, Worsnop CJ, et al. 12-month randomised controlled trial of ginseng extract for moderate COPD. Thorax. 2019;74(6):539–545. doi:10.1136/thoraxjnl-2018-212665
   Web of Science ®Google Scholar
• Preference Collaborative Review Group. Patients’ preferences within randomised trials: systematic review and patient level meta-analysis. BMJ. 2008;337:a1864. doi:10.1136/bmj.a1864
   PubMed Web of Science ®Google Scholar
• Thomas E, Croft PR, Paterson SM, Dziedzic K, Hay EM. What influences participants’ treatment preference and can it influence outcome? Results from a primary care-based randomised trial for shoulder pain. Br J Gen Pract. 2004;54(499):93–96.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tikkinen KAO, Agoritsas T, et al. Patients’ values and preferences of the expected efficacy of hip arthroscopy for osteoarthritis: a protocol for a multinational structured interview-based study combined with a randomised survey on the optimal amount of information to elicit preferences. BMJ Open. 2014;4(10):e005536. doi:10.1136/bmjopen-2014-005536
   Web of Science ®Google Scholar
• van der Weijden T, Légaré F, Boivin A, et al. How to integrate individual patient values and preferences in clinical practice guidelines? A research protocol. Implement Sci. 2010;5:10. doi:10.1186/1748-5908-5-10
   PubMed Web of Science ®Google Scholar
• Global strategy for the diagnosis, management and prevention of copd, global initiative for chronic obstructive lung disease (gold); 2020. Available from: https://goldcopd.org/gold-reports/. Accessed March 2, 2021.
   Google Scholar
• Li X, Thai S, Lu W, et al. Traditional chinese medicine and drug-induced anaphylaxis: data from the beijing pharmacovigilance database. Int J Clin Pharm. 2018;40(4):921–927. doi:10.1007/s11096-018-0699-4
   Web of Science ®Google Scholar
• Yi Y, Li CY, Zhao Y, et al. Safety of animal traditional chinese medicine (tcm) injections. Zhongguo Zhong Yao Za Zhi. 2018;43(22):4391–4396. doi:10.19540/j.cnki.cjcmm.20180711.001
   PubMedGoogle Scholar
• Devereux G, Cotton S, Fielding S, et al. Effect of theophylline as adjunct to inhaled corticosteroids on exacerbations in patients with copd: a randomized clinical trial. JAMA. 2018;320(15):1548–1559. doi:10.1001/jama.2018.14432
   PubMed Web of Science ®Google Scholar
• Poole P, Sathananthan K, Fortescue R. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2019;5(5):CD001287. doi:10.1002/14651858.CD001287.pub6
   Web of Science ®Google Scholar
• Li X, Lu J, Hu S, et al. The primary health-care system in china. Lancet. 2017;390(10112):2584–2594. doi:10.1016/S0140-6736(17)33109-4
   PubMed Web of Science ®Google Scholar
• Dou G, Wang Q, Ying X. Reducing the medical economic burden of health insurance in china: achievements and challenges. Biosci Trends. 2018;12(3):215–219. doi:10.5582/bst.2018.01054
   PubMed Web of Science ®Google Scholar
• Luo H, Li Q, Flower A, Lewith G, Liu J. Comparison of effectiveness and safety between granules and decoction of chinese herbal medicine: a systematic review of randomized clinical trials. J Ethnopharmacol. 2012;140(3):555–567. doi:10.1016/j.jep.2012.01.031
   Web of Science ®Google Scholar
• Celli B, Blasi F, Gaga M, et al. Perception of symptoms and quality of life - comparison of patients’ and physicians’ views in the copd mirror study. Int J Chron Obstruct Pulmon Dis. 2017;12:2189–2196. doi:10.2147/COPD.S136711
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Ferrer J, Baró E, Lleonart M, Galera J. Differences between physician and patient in the perception of symptoms and their severity in copd. Respir Med. 2013;107(12):1977–1985. doi:10.1016/j.rmed.2013.06.019
   PubMed Web of Science ®Google Scholar
• Hernandez P, Balter MS, Bourbeau J, Chan CK, Marciniuk DD, Walker SL. Canadian practice assessment in chronic obstructive pulmonary disease: respiratory specialist physician perception versus patient reality. Can Respir J. 2013;20(2):97–105. doi:10.1155/2013/369019
   PubMed Web of Science ®Google Scholar
• Joseph-Williams N, Elwyn G, Edwards A. Knowledge is not power for patients: a systematic review and thematic synthesis of patient-reported barriers and facilitators to shared decision making. Patient Educ Couns. 2014;94(3):291–309. doi:10.1016/j.pec.2013.10.031
   PubMed Web of Science ®Google Scholar
• Fang L, Gao P, Bao H, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med. 2018;6(6):421–430. doi:10.1016/S2213-2600(18)30103-6
   PubMed Web of Science ®Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar